J.Jill, Inc.
J.Jill, Inc. (JILL) Financial Performance & Income Statement Overview
Explore the financials of J.Jill, Inc. (JILL), including yearly and quarterly data on income, cash flow, and balance sheets.
J.Jill, Inc. (JILL) Income Statement & Financial Overview
Analyze J.Jill, Inc.’s JILL earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $142.84M | $151.26M | $155.24M | $161.51M |
| Cost of Revenue | $48.09M | $43.28M | $45.85M | $49.60M |
| Gross Profit | $94.75M | $107.97M | $109.39M | $111.91M |
| Gross Profit Ratio | $0.66 | $0.71 | $0.70 | $0.69 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $89.31M | $88.65M | $86.31M | $83.57M |
| Operating Expenses | $89.31M | $88.75M | $86.37M | $83.57M |
| Total Costs & Expenses | $137.76M | $132.03M | $132.22M | $133.17M |
| Interest Income | $530000.00 | $494000.00 | $538000.00 | $988000.00 |
| Interest Expense | $2.69M | $2.85M | $3.72M | $6.44M |
| Depreciation & Amortization | $5.24M | $5.25M | $5.004M | $5.83M |
| EBITDA | $11.09M | $24.97M | $20.24M | $34.45M |
| EBITDA Ratio | $0.08 | $0.17 | $0.13 | $0.21 |
| Operating Income | $5.08M | $19.23M | $23.02M | $28.34M |
| Operating Income Ratio | $0.04 | $0.13 | $0.15 | $0.18 |
| Other Income/Expenses (Net) | -$2.16M | -$2.35M | -$11.76M | -$5.45M |
| Income Before Tax | $2.92M | $16.87M | $11.27M | $22.92M |
| Income Before Tax Ratio | $0.02 | $0.11 | $0.07 | $0.14 |
| Income Tax Expense | $670000.00 | $4.52M | $3.08M | $6.23M |
| Net Income | $2.25M | $12.35M | $8.19M | $16.70M |
| Net Income Ratio | $0.02 | $0.08 | $0.05 | $0.10 |
| EPS | $0.15 | $0.81 | $0.55 | $1.17 |
| Diluted EPS | $0.14 | $0.80 | $0.54 | $1.16 |
| Weighted Avg Shares Outstanding | $15.33M | $15.33M | $14.91M | $14.26M |
| Weighted Avg Shares Outstanding (Diluted) | $15.56M | $15.49M | $15.10M | $14.40M |
The company's financials show resilient growth, with revenue advancing from $161.51M in Q1 2024 to $142.84M in Q4 2024. Gross profit remained healthy with margins at 66% in Q4 2024 compared to 69% in Q1 2024. Operating income hit $5.08M last quarter, sustaining a consistent 4% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $11.09M. Net income dropped to $2.25M, while earnings per share reached $0.15. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan